134 results
Page 2 of 7
8-K
EX-99.3
ssorh
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am
S-3ASR
oum27ouyk mt4l0
13 Dec 21
Automatic shelf registration
4:31pm
8-K
EX-99.1
x1x 5s8e4t
16 Nov 21
Regulation FD Disclosure
9:20am
8-K
xyb1tse
4 May 21
Departure of Directors or Certain Officers
4:16pm
8-K
EX-3
xtmt rcjaq8
4 May 21
Departure of Directors or Certain Officers
4:16pm
DEFA14A
7hd7 agea08e04f
19 Apr 21
Additional proxy soliciting materials
7:41am
424B5
zk8mkqskl 9c154kf
12 Nov 20
Prospectus supplement for primary offering
4:21pm
424B3
4xxvqtw
9 Nov 20
Prospectus supplement
8:20am
SC TO-T
EX-99
jjptbe8 hu2z177rfv
19 Oct 20
Third party tender offer statement
6:03am
SC TO-T
EX-99
no89vj9phv7k1z
19 Oct 20
Third party tender offer statement
6:03am
S-3ASR
fow52qz
5 Feb 20
Automatic shelf registration
4:55pm
8-K
EX-25.1
dk4ckl95p1alk
20 Nov 19
Creating a Leading Biopharma Company
5:21pm
8-K
EX-99.1
vhgq46v 1dljmmn
12 Apr 19
Bristol-Myers Squibb Shareholders Approve Celgene Acquisition
5:27pm
8-K
oc8is
12 Apr 19
Bristol-Myers Squibb Shareholders Approve Celgene Acquisition
5:27pm
425
te7kz1 8udan
12 Apr 19
Business combination disclosure
5:25pm